in the US formulary there are over 550 brand named products that contain acetaminophen. Recently, the FDA approved an IV formulation of acetaminophen (OFIRMEV) for the management of postoperative ...

The global paracetamol IV market size was USD 797.08 million in 2024, estimated at USD 823.78 million in 2025, and is expected to reach around USD 1,117.85 million by 2034, expanding at a CAGR of ...

Paracetamol IV Market size was valued at USD 860.7 million in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2034. Paracetamol IV, known for its strong ...

Acetaminophen 1000mg, ibuprofen 300mg; per 100mL; soln for IV infusion; preservative-free. Acetaminophen is a non-opiate, non-salicylate analgesic. The precise mechanism of the analgesic ...

Acetaminophen 10mg/mL; soln for IV infusion; preservative-free. The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily ...

Acetaminophen (APAP, N-acetyl-para-aminophenol, paracetamol) is available over the counter and used widely to relieve mild-to-moderate pain from head and muscle aches, pain secondary to local ...

Intravenous usage of paracetamol is executed in terminally ill patients, post-surgical patients, and pediatric patients who require instant pain treatment. The usage of intravenous paracetamol has ...

(MENAFN- GlobeNewsWire - Nasdaq) Paracetamol IV industry is projected to witness a CAGR of 4.2% during the period 2025-2034. This growth can be attributed to growing adoption in critical care ...